Biodelivery Sciences International reported $113.92M in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acelrx Pharmaceuticals ACRX:US $ -35.99M 8.68M
Adamas Pharmaceuticals ADMS:US -4033000 9.97M
Agile Therapeutics AGRX:US $ 24.61M 10.44M
Antares Pharma ATRS:US $ 132.03M 5.8M
Biocryst Pharmaceuticals BCRX:US $ -106.08M 31.09M
Biodelivery Sciences International BDSI:US $ 113.92M 5.06M
Cara Therapeutics CARA:US $ 203.47M 26.99M
Cti Biopharma CTIC:US $ 61.71M 35.05M
Daiichi Sankyo 4568:JP Y 1280098M 8045M
Depomed DEPO:US $ 92.26M 13.04M
Endo International Ordinary Shares ENDP:US $ -617.04M 18.07M
JAZZ PHA JAZZ:US $ 4131.49M 333.8M
Knight Therapeutics Inc GUD:CN C$ 889.44M 59.96M
Lannett LCI:US $ -27.47M 151.52M
Mannkind MNKD:US $ -183.55M 9.93M
Nektar Therapeutics NKTR:US $ 904.98M 89.53M
Pacira Pharmaceuticals PCRX:US $ 687.17M 36.35M
Redhill Biopharma RDHL:US $ 29.58M 23.46M
Revance Therapeutics RVNC:US $ 186.24M 58.01M
Teva Pharmaceutical TEVA:IT 10.32B 324M